← back to search

Jinwen Feng

Shanghai Jiao Tong University · CN
Area of research
Cancer Research · Oncology
Research interest
Research interests include Cancer, Lipids, and Metabolism, Advanced Proteomics Techniques and Applications, Ferroptosis and cancer prognosis, and Colorectal Cancer Treatments and Studies.
h-index
21
citations
2,099
works
114
NIH funding
primary concept
Medicine
email

Recent publications

Association between gut microbiota and imaging biomarkers in arteriosclerotic cerebral small vessel disease with idiopathic normal pressure hydrocephalus
Frontiers in Neuroscience 2026cited by 0position: middledoi
Cancer biomarkers discovered using pan-cancer plasma proteomic profiling
Nature Biomedical Engineering 2025cited by 7position: middledoi
Longitudinal plasma proteome profiling reveals the diversity of biomarkers for diagnosis and cetuximab therapy response of colorectal cancer
Nature Communications 2024cited by 32position: middledoi
Proteogenomic characterization of skull-base chordoma
Nature Communications 2024cited by 13position: middledoi
Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression
Cancer Research 2024cited by 11position: middledoi
Integrative proteogenomic characterization of early esophageal cancer
Nature Communications 2023cited by 64position: middledoi
Proteogenomics of diffuse gliomas reveal molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms
Nature Communications 2023cited by 39position: middledoi
Proteogenomics of clear cell renal cell carcinoma response to tyrosine kinase inhibitor
Nature Communications 2023cited by 28position: middledoi
Comprehensive proteogenomic characterization of early duodenal cancer reveals the carcinogenesis tracks of different subtypes
Nature Communications 2023cited by 24position: middledoi
Plasma proteomic profiling discovers molecular features associated with upper tract urothelial carcinoma
Cell Reports Medicine 2023cited by 22position: middledoi
Proteogenomics of different urothelial bladder cancer stages reveals distinct molecular features for papillary cancer and carcinoma in situ
Nature Communications 2023cited by 22position: middledoi
Proteomic characterization of the colorectal cancer response to chemoradiation and targeted therapies reveals potential therapeutic strategies
Cell Reports Medicine 2023cited by 21position: middledoi
Proteomic Characterization Identifies Clinically Relevant Subgroups of Gastrointestinal Stromal Tumors
Gastroenterology 2023cited by 18position: middledoi
A proteogenomic analysis of clear cell renal cell carcinoma in a Chinese population
Nature Communications 2022cited by 145position: middledoi
Integrated proteogenomic characterization of urothelial carcinoma of the bladder
Journal of Hematology & Oncology 2022cited by 100position: middledoi
Integrated proteogenomic characterization across major histological types of pituitary neuroendocrine tumors
Cell Research 2022cited by 83position: middledoi
Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals potential therapeutic strategies
Nature Communications 2022cited by 79position: middledoi
Proteogenomic characterization of MiT family translocation renal cell carcinoma
Nature Communications 2022cited by 71position: middledoi
Proteogenomic characterization of cholangiocarcinoma
Hepatology 2022cited by 55position: middledoi
Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma
Journal of Hematology & Oncology 2022cited by 47position: middledoi
Blood molecular markers associated with COVID‐19 immunopathology and multi‐organ damage
The EMBO Journal 2020cited by 187position: middledoi
rPTMDetermine: A Fully Automated Methodology for Endogenous Tyrosine Nitration Validation, Site-Localization, and Beyond
Analytical Chemistry 2020cited by 4position: middledoi
Chinese newborn screening for the incidence of G6PD deficiency and variant of G6PD gene from 2013 to 2017
Human Mutation 2019cited by 59position: middledoi
A proteomic landscape of diffuse-type gastric cancer
Nature Communications 2018cited by 320position: middledoi
Firmiana: towards a one-stop proteomic cloud platform for data processing and analysis
Nature Biotechnology 2017cited by 221position: firstdoi
A mouse tissue transcription factor atlas
Nature Communications 2017cited by 138position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Chen Ding · Beijing University of Chemical Technology16 papers (2022–2024)Zhaoyu Qin · Fudan University11 papers (2022–2024)Jian‐Yuan Zhao · Chinese Academy of Medical Sciences & Peking Union Medical College11 papers (2022–2023)Yunzhi Wang · XinHua Hospital11 papers (2022–2024)Subei Tan · Fudan University10 papers (2022–2024)Yingyong Hou · Shanghai Medical College of Fudan University10 papers (2022–2024)Sha Tian · Fudan University7 papers (2022–2023)Yang Liu · The First People's Hospital of Changde7 papers (2017–2023)Jiajun Zhu · Fudan University6 papers (2022–2024)Fujiang Xu · Fudan University6 papers (2022–2023)Dongxian Jiang · U.S. National Science Foundation6 papers (2022–2024)Yuanyuan Qu · Fudan University5 papers (2022–2023)Lin Bai · Peking University5 papers (2022–2023)Fahan Ma · Fudan University4 papers (2022–2024)Xiaohui Wu · Fudan University4 papers (2022–2023)Qiao Zhang · Fudan University4 papers (2023–2024)Chen Xu · State University "Kyiv Aviation Institute"4 papers (2022–2024)Dalong Cao · Fudan University3 papers (2022–2023)Chen Ding · Fudan University3 papers (2017–2024)Kai Li · Fudan University3 papers (2022–2024)